DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 246 participants.

Also called NCT02666742

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 246 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02666742
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02666742. Randomized; no masking; primary purpose prevention. Start 2017-02-16 (actual); primary completion 2020-05-01 (actual). Results posted on 2021-09-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
Acronym
STROKE-VT
Condition
Ventricular Tachycardia
Condition
Premature Ventricular Contraction
Condition
Stroke
Intervention (Drug)
DOAC
Intervention (Drug)
Aspirin
Lead sponsor
Kansas City Heart Rhythm Institute (class: other)
Collaborator
Kansas City Heart Rhythm Research Foundation (class: other)

Record details

Record id
cardio:ct-nct02666742
Content hash
a8681c03a077c0bd1e9dacf70f5078760333b334c15ec2105288fb23f4f9f3f6